Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Certain drugs that block specific enzymes can help treat prostate diseases.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Testosterone may slow down wound healing and increase inflammation.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Combination of 17α-estradiol and minoxidil improves hair growth and reduces hair loss in most patients.